H-Tyr(2,6-Cl2-Bzl)-OH CAS:40298-69-9

Mukugadzirwa kwepeptide, H-Tyr(2,6-Cl2-Bzl)-OH inoita basa rakakosha se amino acid derivative yakachengetedzwa inosangana ne coupling reactions kuti igadzire peptide chains, inowanzo shanda se C-terminal amino acid. Maitiro aya anoda kunyatso tarisa mamiriro e reaction uye matekiniki ekuchenesa kuchengetedza kusimba kwe compound uye kugadzira zvigadzirwa zve peptide zvemhando yepamusoro. Vatsvaguriri nesainzi yemishonga vanobatanidza H-Tyr(2,6-Cl2-Bzl)-OH mu synthetic protocols dzavo kuti vagadzire peptide sequences chaiyo inoratidza biological activity kana therapy potential. Kuchena uye kugadzikana kwe compound kwakakosha pakuona mhedzisiro inodzokororwa mukugadzirwa kwe peptide, zvichibatsira mukuvandudzwa kwemishonga mitsva uye bioactive compounds. Uyezve, H-Tyr(2,6-Cl2-Bzl)-OH inoenderana nenzira dzakasimba dze solid-phase synthesis inoita kuti ishandiswe zvakanaka mu automated peptide synthesizers, zvichiita kuti kugadzirwa kwe custom peptides nema peptide libraries ekuwana mishonga uye mashandisirwo ekutsvagisa. Basa rayo mukugadzira ma peptide structures akasiyana-siyana rinoita kuti ive yakakosha pakugadzirisa matambudziko akasiyana-siyana e biomedical uye kutsvaga nzira itsva dzekurapa. Zvose, kukosha kweH-Tyr(2,6-Cl2-Bzl)-OH mukugadzirwa kwepeptide kunosvika pakutsvagurudza kwemishonga, biotechnology, uye chemistry yekurapa, uko kunoramba kuchibatsira kugadzirwa kwemishonga mitsva yakavakirwa papeptide uye biopharmaceuticals, zvichitungamira kufambira mberi muhutano nesainzi yehupenyu.